Murray, CJ, Lopez, AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet
1997; 349: 1436–42.
Judd, LL, Akiskal, HS, Schettler, PJ, Coryell, W, Endicott, J, Maser, JD, et al. A prospective investigation of the natural history of the long-term weekly 8 Lamotrigine for treatment of bipolar depression symptomatic status of bipolar II disorder. Arch Gen Psychiatry
2003; 60: 261–9.
Judd, LL, Akiskal, HS, Schettler, PJ, Endicott, J, Maser, J, Solomon, DA, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry
2002; 59: 530–7.
Kupfer, DJ, Frank, E, Grochocinski, VJ, Luther, JF, Houck, PR, Swartz, NA, et al. Stabilization in the treatment of mania, depression and mixed states. Acta Neuropsychiatrica
2000; 12: 110–4.
Gijsman, HJ, Geddes, JR, Rendell, JM, Nolen, WA, Goodwin, GM. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry
2004; 161: 1537–47.
Sachs, GS, Nierenberg, AA, Calabrese, JR, Marangell, LB, Wisniewski, SR, Gyulai, L, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med
2007; 356: 1711–22.
American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry
2002; 159 (suppl 4): 1–50.
Marangell, LB, Martinez, JM, Ketter, TA, Bowden, CL, Goldberg, JF, Calabrese, JR, et al; for the STEP-BD Investigators. Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BD. Bipolar Disord
2004; 6: 139–43.
Calabrese, JR, Huffman, RF, White, RL, Edwards, S, Thompson, TR, Ascher, JA, et al. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials. Bipolar Disord
2008; 10: 323–33.
Stewart, LA, Clarke, MJ. Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group. Stat Med
1995; 14: 2057–79.
Clarke, MJ, Stewart, LA. Obtaining data from randomised controlled trials: how much do we need for reliable and informative meta-analyses?
1994; 309: 1007–10.
First, MB, Gibbon, M, Spitzer, RL, Williams, JBW. Structured Clinical Interview for DSM–IV Axis I Disorders Research Version (SCID–I). Biometric Research, New York State Psychiatric Institute, 1996.
Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiatry
1960; 23: 56–62.
Montgomery, SA, Åsberg, M. A new depression scale designed to be sensitive to change. Br J Psychiatry
1979; 134: 382–9.
National Collaborating Centre for Mental Health. Depression: Management of Depression in Primary and Secondary Care. National Institute for Health and Clinical Excellence, 2004 (http://www.nice.org.uk/page.aspx?o=235213).
Thompson, SG, Higgins, JPT. How should meta-regression analyses be undertaken and interpreted?
2002; 21: 1559–73.
Sharp, SJ. Meta-analysis regression. Stata Technic Bull
1998; 42: 16–22.
Frye, MA, Ketter, TA, Kimbrell, TA, Dunn, RT, Speer, AM, Osuch, EA, et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol
2000; 20: 607–14.
van der Loos, M, Nolen, WA, Vieta, E. Lamotrigine as add-on to lithium in bipolar disorder. Bipolar Disord
2007; 9 (suppl 1): 107.
Montaner, JS, O'Shaughnessy, MV, Schechter, MT. Industry-sponsored clinical research: a double-edged sword. Lancet
2002; 358: 1893–5.
Charney, DS, Nemeroff, CB, Lewis, L, Laden, SK, Gorman, JM, Laska, EM, et al. National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. Arch Gen Psychiatry
2002; 59: 262–70.
Geddes, JR, Cipriani, A. Selective serotonin reuptake inhibitors. BMJ
2004; 329: 809–10.
Calabrese, JR, Rapport, DJ, Shelton, MD, Kimmel, SE. Evolving methodologies in bipolar disorder maintenance research. Br J Psychiatry
2001; 178 (suppl 41): s157–63.
Calabrese, JR. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry
2005; 162: 1351–60.
Thase, ME, Macfadden, W, Weisler, RH, Chang, W, Paulsson, B, Khan, A, et al; for the BOLDER II Study Group. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol
2006; 26: 600–9.
Chalmers, TC, Lau, J. Meta-analytic stimulus for changes in clinical trials. Stat Methods Med Res
1993; 2: 161–72.
Easterbrook, PJ, Berlin, JA, Gopalan, R, Matthews, DR. Publication bias in clinical research. Lancet
1991; 337: 867–72.